Unknown

Dataset Information

0

Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation.


ABSTRACT: Autophagy is a fundamental housekeeping process by which cells degrade their components to maintain homeostasis. Defects in autophagy have been associated with aging, neurodegeneration and metabolic diseases. Non-alcoholic fatty liver diseases (NAFLDs) are characterized by hepatic fat accumulation with or without inflammation. No treatment for NAFLDs is currently available, but autophagy induction has been proposed as a promising therapeutic strategy. Here, we aimed to design autophagy-inducing particles, using the autophagy-inducing peptide (Tat-Beclin), and achieve liver targeting in vivo, taking NAFLD as a model disease. Polylactic acid (PLA) particles were prepared by nanoprecipitation without any surfactant, followed by surface peptide adsorption. The ability of Tat-Beclin nanoparticles (NP T-B) to modulate autophagy and to decrease intracellular lipid was evaluated in vitro by LC3 immunoblot and using a cellular model of steatosis, respectively. The intracellular localization of particles was evaluated by transmission electron microscopy (TEM). Finally, biodistribution of fluorescent NP T-B was evaluated in vivo using tomography in normal and obese mice. The results showed that NP T-B induce autophagy with a long-lasting and enhanced effect compared to the soluble peptide, and at a ten times lower dose. Intracellular lipid also decreased in a cellular model of NAFLD after treatment with T-B and NP T-B under the same dose conditions. Ultrastructural studies revealed that NP T-B are internalized and located in endosomal, endolysosomal and autolysosomal compartments, while in healthy and obese mice, NP T-B could accumulate for several days in the liver. Given the beneficial effects of autophagy-inducing particles in vitro, and their capacity to target the liver of normal and obese mice, NP T-B could be a promising therapeutic tool for NAFLDs, warranting further in vivo investigation.

SUBMITTER: Zagkou S 

PROVIDER: S-EPMC9318411 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8397667 | biostudies-literature
| S-EPMC7828486 | biostudies-literature
2022-11-21 | E-MTAB-10118 | biostudies-arrayexpress
| S-EPMC1810559 | biostudies-literature
| S-EPMC9772986 | biostudies-literature
| S-EPMC5466434 | biostudies-literature
| S-EPMC8333048 | biostudies-literature
| S-EPMC6060103 | biostudies-literature
| S-EPMC9908577 | biostudies-literature
| S-EPMC6433726 | biostudies-literature